Emami Menthoplus universal oil

Indications

• Localized neuropathic pain
• Post-herpetic neuralgia
• Painful diabetic neuropathy

Dosage

Adults: Apply 3–4 times a day, using 0.075% strength, apply sparingly, and not more often than every 4 hours.

Mechanism of action

Capsaicin acts as an agonist of the TRPV1 (transient receptor potential vanilloid 1) receptor. Upon activation by capsaicin, the TRPV1 receptor opens to allow the influx of cations, particularly calcium and sodium ions, leading to depolarization of sensory neurons. This results in the induction of pain responses initially, followed by desensitization or 'defunctionalization' of nociceptor fibers, which reduces pain signaling over time. Capsaicin reduces levels of substance P, a neuropeptide associated with pain transmission, contributing to its analgesic effects.

Pharmacodynamics

Capsaicin's interaction with TRPV1 receptors leads to a series of cellular responses, including temporary loss of membrane potential and alterations in neurotrophic factor transport. The prolonged exposure to capsaicin results in persistent activation of these receptors, causing a loss of response to sensory stimuli, which is described as defunctionalization. This process results in significant changes in neuronal excitability and pain perception.

Pharmacokinetics

Capsaicin is primarily applied topically, allowing for localized effects with minimal systemic absorption. The pharmacokinetics of capsaicin involve rapid uptake into the skin and subsequent receptor-mediated effects. The duration of action can vary based on the concentration and formulation used. Capsaicin undergoes metabolism in the liver, and its effects can last for hours to days due to the desensitization of nociceptive pathways.

Contra-indications

• Known hypersensitivity to capsaicin or any of the excipients
• History of cardiovascular disease in diabetic patients
• Uncontrolled hypertension

Adverse effects

• Burning sensation at the application site
• Skin irritation
• Eye irritation if in contact with eyes
• Cough
• Dry mouth
• Nausea
• Palpitations
• Taste alterations
• Throat irritation
• Muscle spasms
• Sneezing
• Watering eyes
• Peripheral edema
• Tachycardia

Interactions

• Use with caution in patients taking other analgesics
• May enhance the effects of medications that affect blood pressure
• Avoid using with other topical agents that may irritate the skin

Precautions

• Avoid contact with broken or inflamed skin
• Wash hands immediately after use
• Wear nitrile gloves when applying patches
• Avoid contact with eyes and mucous membranes
• Avoid hot showers or baths just before or after application
• Monitored use in diabetic patients with cardiovascular disease
• Regular monitoring for side effects in long-term therapy

Pregnancy

Capsaicin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Consult with a healthcare provider.

Breast-feeding

Use with caution while breastfeeding. Consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Topical cream (0.075%)
• Transdermal patches (Qutenza®)

Dosage

Children: Refer to specific formulations and usages, as dosing can vary widely depending on the application and regulatory guidelines.

Adults: Refer to specific formulations and usages, as dosing can vary widely depending on the application and regulatory guidelines.

Mechanism of action

Butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) act as antioxidants by inhibiting the oxidation of lipids. They scavenge free radicals and donate hydrogen atoms to reactive species, thus stabilizing and preventing oxidative damage to cellular components. This action helps to protect the integrity of cell membranes and prevent the formation of harmful peroxides.

Pharmacodynamics

The pharmacodynamic properties of butylated compounds are primarily related to their antioxidant activity. They exhibit a dose-dependent ability to inhibit lipid peroxidation, which is crucial in protecting cells from oxidative stress. Furthermore, they may modulate certain biochemical pathways involved in cell signaling and apoptosis, although these effects are less well-characterized.

Pharmacokinetics

Butylated compounds are absorbed from the gastrointestinal tract following oral ingestion. They undergo metabolic processing primarily in the liver, where they are conjugated and excreted in urine. The half-life of butylated compounds in humans is variable, influenced by factors such as dosage and individual metabolism. Accumulation in tissues is generally low, but prolonged exposure may lead to higher tissue concentrations.

Adverse effects

• Gastrointestinal disturbances
• Allergic reactions
• Potential carcinogenic effects with prolonged exposure

Precautions

• Use with caution in patients with a history of hypersensitivity to butylated compounds
• Avoid prolonged exposure due to potential toxicity

Pregnancy

Limited data available, use only if the benefits outweigh the risks.

Breast-feeding

Unknown, exercise caution and consult a healthcare provider.

Storage

Store in a cool, dry place away from light.

Formulations

• Butylated hydroxytoluene (BHT)
• Butylated hydroxyanisole (BHA)

Indications

• Topical antiseptic
• Analgesic for muscle and joint pain
• Respiratory conditions, such as colds and coughs
• Anti-inflammatory treatment

Dosage

Children: Pediatric use should be approached with caution. It is advisable to consult a healthcare professional before administering cajeput oil to children, ensuring appropriate dilution and method of application.

Adults: Application of cajeput oil should be done according to product-specific instructions, typically diluted with a carrier oil for topical use. For inhalation, a few drops can be added to a bowl of hot water to create steam.

Mechanism of action

Cajeput oil contains various bioactive compounds, including 1,8-cineole (eucalyptus oil), which contribute to its therapeutic properties. The primary mechanism of action includes modulation of ion channels and receptors, particularly influencing the TRPV1 receptor involved in pain and inflammation pathways. Additionally, its antimicrobial effects may arise from disrupting the cell membranes of bacteria and fungi.

Pharmacodynamics

The pharmacodynamics of cajeput oil involve its interaction with pain and inflammation pathways, leading to a reduction in discomfort. Its antiseptic and antimicrobial properties help in preventing infections, while its aromatic compounds may provide relief in respiratory ailments by promoting expectoration and calming respiratory tract irritation.

Pharmacokinetics

Cajeput oil is absorbed through the skin when applied topically and can also be inhaled to reach the lungs. The absorption may vary based on the method of application. Following absorption, its components are metabolized in the liver, and excreted primarily through urine. The half-life of the individual constituents can vary, influencing the duration of action.

Adverse effects

• Skin irritation
• Allergic reactions
• Gastrointestinal upset

Precautions

• Use with caution in individuals with allergies, particularly to plants in the Myrtaceae family
• Should not be applied to broken skin or open wounds

Pregnancy

Cajeput oil should be used with caution during pregnancy, as safety has not been established.

Breast-feeding

It is advisable to avoid the use of cajeput oil while breastfeeding due to insufficient safety data.

Storage

Store in a cool, dry place away from direct sunlight. Keep container tightly closed.

Formulations

• Essential oil

Indications

• Topical pain relief
• Muscle aches
• Joint pain
• Inflammation

Dosage

Children: For children, the

Adults: For topical application, camphor is usually applied as needed to the affected area, following the instructions on the specific product used. Consult the product label or a healthcare professional for detailed dosing guidelines.

Mechanism of action

Camphor activates the transient receptor potential vanilloid 1 (TRPV1) and TRPV3 channels, which are involved in sensing pain and temperature. It requires higher concentrations to activate TRPV1 compared to capsaicin but notably desensitizes TRPV1 more rapidly and completely. This action is enhanced under inflamed conditions through phospholipase C-coupled receptor stimulation. The distinct activation pathways of camphor contribute to its analgesic effects, making it effective in reducing pain sensitivity.

Pharmacodynamics

The pharmacodynamic properties of camphor are primarily related to its interaction with TRPV1 and TRPV3 channels. By activating these receptors, camphor induces a sensation of warmth and can result in analgesia through sensory nerve excitation and subsequent desensitization. This mechanism is similar to that of other topical analgesics like capsaicin and menthol but is characterized by a faster desensitization of TRPV1. Additionally, camphor's effects may include local vasodilation and increased blood flow to the area of application, which can further alleviate pain and inflammation.

Pharmacokinetics

Camphor is absorbed through the skin when applied topically. Its pharmacokinetic profile involves distribution to various tissues, where it can exert local effects. The metabolism of camphor occurs primarily in the liver, and it is eliminated from the body mainly through urine. The onset of action is typically rapid due to its topical application, and the duration of effect may vary depending on the formulation and concentration used.

Adverse effects

• Skin irritation
• Allergic reactions
• Nausea
• Vomiting
• Dizziness

Precautions

• Use with caution in individuals with sensitive skin
• Avoid contact with eyes and mucous membranes
• Do not apply to broken or irritated skin
• Keep out of reach of children

Pregnancy

Camphor should be used with caution during pregnancy. It is advisable to consult a healthcare professional before use.

Breast-feeding

Camphor should be used with caution while breastfeeding. Consult a healthcare professional for advice.

Storage

Store in a cool, dry place, away from direct sunlight and heat.

Formulations

• Topical ointments
• Liniments
• Creams
• Gels

Indications

• Pain relief
• Anti-inflammatory conditions
• Antimicrobial applications
• Dental pain
• Digestive disorders

Dosage

Children: Refer to healthcare professional for appropriate dosing guidelines as clove oil is generally not recommended for children without medical supervision.

Adults: For topical application, clove oil can be diluted with a carrier oil and applied as needed. For oral use, standard culinary doses are generally considered safe, but specific therapeutic doses should be guided by a healthcare professional.

Mechanism of action

Eugenol, the primary active compound in clove, exhibits its effects through several pathways. It acts as an analgesic by inhibiting the synthesis of prostaglandins, which are mediators of pain and inflammation. Additionally, eugenol has been shown to interact with voltage-gated sodium channels, which may contribute to its analgesic effects. Its antimicrobial properties are partly due to its ability to disrupt the cell membranes of bacteria and fungi.

Pharmacodynamics

Clove has a variety of pharmacodynamic effects, primarily attributed to eugenol. It exhibits analgesic, anti-inflammatory, and antioxidant properties. Clove oil has been found to reduce pain and inflammation in various experimental models. Its antimicrobial activity is effective against a range of pathogens, making it a candidate for use in oral health products. Furthermore, the antioxidant properties help in neutralizing free radicals, thereby providing protective effects against cellular damage.

Pharmacokinetics

Clove oil is absorbed through the gastrointestinal tract when ingested and can also be absorbed through the skin when applied topically. The bioavailability of eugenol can be influenced by its formulation and method of administration. Once absorbed, eugenol is distributed throughout the body, metabolized primarily in the liver, and excreted via the kidneys. The half-life of eugenol varies but is generally short, necessitating frequent dosing for sustained effects in therapeutic use.

Adverse effects

• Allergic reactions
• Gastrointestinal irritation
• Liver toxicity with excessive use
• Hypoglycemia

Interactions

• May enhance the effects of anticoagulants
• May interact with antidiabetic medications
• May reduce the effectiveness of certain antiepileptic drugs

Precautions

• Use with caution in individuals with liver disease
• Caution in patients with bleeding disorders
• Monitor blood sugar levels in diabetics

Pregnancy

Use during pregnancy is not recommended due to potential effects on the fetus.

Breast-feeding

Limited data available; use with caution as clove can affect milk production.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Essential oil
• Dried whole cloves
• Powdered clove

Indications

• Respiratory infections
• Cough and cold symptoms
• Sinusitis
• Bronchitis
• Muscle pain and inflammation

Dosage

Children: Refer to specific product guidelines or consult a healthcare professional for appropriate dosing of eucalyptus oil in children, as it varies based on formulation and indication.

Adults: Refer to specific product guidelines or consult a healthcare professional for appropriate dosing of eucalyptus oil, as it varies based on formulation and indication.

Mechanism of action

Eucalyptus oil contains compounds such as eucalyptol (1,8-cineole) that exhibit antimicrobial properties. It acts on the respiratory system by promoting bronchodilation and reducing mucus production. The oil also has a cooling effect, which can provide relief from symptoms of respiratory distress. Additionally, the oil's anti-inflammatory properties help decrease inflammation in the airways.

Pharmacodynamics

The primary active ingredient in eucalyptus oil, eucalyptol, interacts with the body's inflammatory response and can modulate the activity of neurotransmitters involved in pain signaling. It may enhance mucociliary clearance in the respiratory tract, facilitating the expulsion of mucus and pathogens. The analgesic effects can help relieve discomfort associated with respiratory infections.

Pharmacokinetics

Eucalyptus oil is typically administered via inhalation or topical application. When inhaled, components like eucalyptol are absorbed through the mucous membranes of the respiratory tract and rapidly distributed throughout the body. The oil is metabolized primarily in the liver, and its metabolites are excreted in urine. The half-life of eucalyptol varies but is generally short, necessitating frequent dosing for sustained effects.

Adverse effects

• Allergic reactions
• Skin irritation
• Nausea
• Vomiting
• Diarrhea
• Dizziness

Interactions

• May interact with anticoagulants, potentially increasing bleeding risk
• May enhance the effects of other medications that cause sedation

Precautions

• Use with caution in individuals with asthma or other respiratory conditions
• Avoid use in young children without medical supervision
• Eucalyptus oil should not be ingested in large quantities due to toxicity

Pregnancy

Eucalyptus oil is generally considered unsafe in pregnancy due to potential toxicity and should be avoided unless prescribed by a healthcare professional.

Breast-feeding

Caution is advised when using eucalyptus during breastfeeding, as it may pass into breast milk and could affect the infant.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Eucalyptus oil (topical, inhalation, or oral preparations)
• Eucalyptus leaves (dried for teas or extracts)

Indications

• Anxiety disorders
• Nausea and vomiting
• Allergic conditions
• Preoperative sedation
• Pruritus

Dosage

Children: Refer to the BNF for Children for appropriate dosing recommendations based on age and weight.

Adults: Refer to the BNF for specific dosing guidelines based on the indication and patient characteristics.

Mechanism of action

Hydroxyzine works by antagonizing the H1 histamine receptors, leading to a reduction in the effects of histamine in the body. This action helps alleviate symptoms of allergic reactions and promotes sedation. Additionally, it may exert effects on serotonin and adrenergic receptors, which could contribute to its anxiolytic properties. Hydroxyzine is also involved in various metabolic pathways, including selenium metabolism and the degradation of reactive oxygen species.

Pharmacodynamics

The pharmacodynamic effects of hydroxyzine include sedation, anxiolysis, and reduction of allergic symptoms. Its sedative effects can make it useful in managing anxiety and inducing sleep, while its antihistaminic properties help to relieve symptoms such as itching and rashes associated with allergic reactions. The onset of action is typically within 15 to 30 minutes when taken orally, with peak effects occurring within 1 to 2 hours.

Pharmacokinetics

Hydroxyzine is well absorbed from the gastrointestinal tract, with peak plasma concentrations occurring approximately 2 hours after oral administration. It is extensively metabolized in the liver, with metabolites, including cetirizine, possessing their own therapeutic effects. Hydroxyzine has a half-life of approximately 20 hours, allowing for once or twice daily dosing. It is primarily excreted in the urine, with less than 1% of the unchanged drug found in urine.

Interactions

• hydroxyzine+antiepileptics: Severe (increases risk of overheating and dehydration)
• hydroxyzine+zonisamide: Severe (increases risk of overheating and dehydration)
• hydroxychloroquine+penicillamine: Severe (increases risk of haematological toxicity)
• hydroxychloroquine+agalsidase alfa: Unknown (decreases effects)
• hydroxychloroquine+agalsidase beta: Unknown (decreases exposure)
• hydroxychloroquine+oral cholera vaccine: Unknown (decreases efficacy)
• live vaccines+hydroxy carbamide: Unknown (increases risk of generalised infection (possibly life-threatening))
• lanthanum+hydroxychloroquine: Unknown (decreases absorption)
• macrolides+hydroxychloroquine: Unknown (increases risk of serious cardiovascular adverse effects)
• hydroxychloroquine+remdesivir: Unknown (decreases effects)

Pregnancy

Safety in pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Use with caution. Hydroxychloroquine is excreted in breast milk, and effects on the infant are unknown.

Storage

Store in a cool, dry place, protected from light. Keep out of reach of children.

Formulations

• Tablets
• Oral solution

Indications

• Antiseptic for skin disinfection
• Solvent in pharmaceutical formulations
• Cleaning agent in laboratories and healthcare settings

Dosage

Children: For pediatric use, consult specific guidelines in the BNF for Children, as dosing may vary based on age, weight, and clinical circumstances.

Adults: For skin antisepsis, apply isopropyl alcohol topically in a concentration of 70% to the affected area. Dosage may vary based on clinical indication and setting.

Mechanism of action

Isopropyl alcohol works primarily as an antiseptic by denaturing proteins and disrupting cell membranes of bacteria, viruses, and fungi, leading to cell lysis and death. Its efficacy is enhanced by the presence of water, which facilitates the penetration of the alcohol into microbial cells.

Pharmacodynamics

Isopropyl alcohol exhibits a rapid onset of action against a variety of pathogens, including gram-positive and gram-negative bacteria, fungi, and some viruses. Its antimicrobial activity is concentration-dependent, with higher concentrations generally providing a broader spectrum of activity. It is commonly used in concentrations ranging from 60% to 90%, with 70% being optimal for disinfection due to its ability to penetrate the cell wall effectively.

Pharmacokinetics

Isopropyl alcohol is readily absorbed through the skin and mucous membranes. After absorption, it is metabolized primarily in the liver to acetone, which is then further metabolized and excreted, mostly via urine. The elimination half-life of isopropyl alcohol varies but is typically around 2 to 3 hours. Its effects can be influenced by factors such as dosage, route of exposure, and individual metabolic differences.

Pregnancy

Isopropyl alcohol should be used with caution during pregnancy. It is a category C drug, indicating that risk cannot be ruled out.

Breast-feeding

Caution is advised when using isopropyl alcohol during breastfeeding, as it is not known if it is excreted in human milk.

Storage

Isopropyl alcohol should be stored at room temperature, away from heat and flame. Keep the container tightly closed and in a well-ventilated area.

Formulations

• Isopropyl alcohol 70% solution
• Isopropyl alcohol 99% solution

Dosage

Children: Refer to specific product information or clinical guidelines for appropriate dosing, as it varies widely by the formulation and intended use.

Adults: Refer to specific product information or clinical guidelines for appropriate dosing, as it varies widely by the formulation and intended use.

Mechanism of action

The mechanism of action of liquid formulations can vary significantly based on their components. For example, if liquidum refers to a hydration solution, the mechanism may involve the replenishment of fluids and electrolytes to maintain cellular function and homeostasis. In other contexts, the active ingredients may exert their effects through specific biochemical pathways or interactions with receptor sites in the body.

Pharmacodynamics

Pharmacodynamics relates to the effects of liquidum on the body, which will depend on its specific composition. Hydration solutions generally aim to restore fluid balance, while therapeutic liquids containing drugs may interact with specific receptors or enzymes, leading to various biological responses. The efficacy and safety profile will depend on the concentration and formulation of the active ingredients.

Pharmacokinetics

The pharmacokinetics of liquidum formulations will vary based on the specific agents included. Generally, pharmacokinetic properties such as absorption, distribution, metabolism, and excretion are influenced by the physical state of the medication (liquid), its solubility, and its formulation. For instance, oral liquid medications may have different absorption rates compared to intravenous formulations. The onset of action, peak effect, and duration of action will also depend on these factors.

Pregnancy

Consult a healthcare professional before use during pregnancy.

Breast-feeding

Consult a healthcare professional before use while breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Topical analgesic for muscle and joint pain
• Cough suppressant in cough drops and lozenges
• Relief of minor throat irritation
• Cooling agent in various cosmetic and personal care products

Dosage

Children: Refer to BNF for Children for specific dosing guidelines, as doses may vary based on age and formulation.

Adults: For topical use, apply a thin layer to the affected area not more than 3 to 4 times daily. For cough drops, follow the product-specific instructions as per the formulation.

Mechanism of action

Menthol acts as an agonist for the transient receptor potential subtype M8 (TRPM8), a non-selective cation channel that is activated by cold temperatures. This activation leads to calcium influx in mast cells, inducing the release of histamine, which can trigger allergic responses such as urticaria, asthma, and rhinitis. Menthol's ability to induce histamine release via TRPM8 suggests potential therapeutic applications for TRPM8 antagonists in managing cold- and menthol-induced allergies.

Pharmacodynamics

Menthol produces a cooling effect by stimulating sensory neurons that convey cold sensations. It interacts with TRPM8 channels, leading to the activation of intracellular signaling pathways that can result in vasodilation and increased blood flow to the area of application. This cooling sensation can provide symptomatic relief in conditions characterized by pain or irritation.

Pharmacokinetics

Menthol is absorbed through the skin and mucous membranes, with systemic effects depending on the route of administration. Its bioavailability can vary, and it is metabolized primarily in the liver. The elimination half-life and excretion pathways have not been extensively characterized, but menthol is generally considered to have a rapid onset of action with effects lasting for a few hours.

Adverse effects

• Allergic reactions
• Urticaria
• Asthma
• Rhinitis
• Skin irritation

Precautions

• Use with caution in patients with known allergies to menthol or related compounds
• May exacerbate asthma in sensitive individuals

Pregnancy

There are no well-controlled studies of menthol in pregnant women. Menthol should be used during pregnancy only if clearly needed.

Breast-feeding

Menthol is excreted in breast milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Formulations

• Topical ointment
• Cream
• Liquid

Indications

• Acute pain
• Chronic pain
• Inflammatory conditions
• Osteoarthritis
• Rheumatoid arthritis
• Postoperative pain

Dosage

Children: Refer to specific pediatric dosing guidelines as established in authoritative references, ensuring consideration of the child's age, weight, and clinical condition.

Adults: Refer to specific prescribing guidelines or clinical protocols for adult dosing, as it may vary based on the condition being treated and the formulation used.

Mechanism of action

Myristrate acts by inhibiting cyclooxygenase (COX) enzymes, leading to a decrease in the production of prostaglandins. This results in reduced inflammation and pain. The drug may also exert effects on peripheral pain receptors, further contributing to its analgesic properties.

Pharmacodynamics

The pharmacodynamics of myristrate involve its ability to modulate inflammatory pathways and pain signaling. By inhibiting COX enzymes, myristrate decreases the synthesis of pro-inflammatory mediators, leading to a reduction in the clinical manifestations of pain and inflammation. The onset of analgesic effects can occur within a few hours of administration, with peak effects typically seen within several hours.

Pharmacokinetics

Myristrate is generally well absorbed following oral administration, with peak plasma concentrations occurring within 1 to 2 hours. The drug is metabolized primarily in the liver, with various metabolic pathways contributing to its clearance from the body. Its elimination half-life can vary, but it is typically in the range of several hours. Excretion occurs mainly through the urine, with both unchanged drug and metabolites being eliminated.

Pregnancy

There is limited information on the use of myristrate in pregnancy. It is advisable to use caution and consult a healthcare professional before use.

Breast-feeding

Myristrate should be used cautiously during breastfeeding, as its effects on a nursing infant are not well-studied.

Storage

Store at room temperature, away from direct sunlight and moisture. Keep out of reach of children.

Indications

• Constipation
• Dry skin
• Dermatitis
• Eczema

Dosage

Children: Refer to the BNF for Children for specific dosing information tailored to pediatric patients.

Adults: Refer to the BNF for specific dosing information as it can vary based on the formulation and intended use.

Mechanism of action

Paraffinum works primarily by coating the stool and the intestinal lining, which helps to retain water in the intestines, facilitating softer stools and promoting bowel movements. This action reduces the absorption of water from the stool, making evacuation easier.

Pharmacodynamics

Paraffinum exhibits its effects as a lubricant and stool softener. Its hydrophobic nature allows it to create a barrier that reduces friction in the gastrointestinal tract, thus easing the passage of stool. The onset of its laxative effect can vary, often occurring within 6 to 8 hours when taken orally, depending on the individual’s digestive transit time.

Pharmacokinetics

Paraffinum is not significantly absorbed through the gastrointestinal tract, which means it primarily acts locally within the intestines. Its effects are predominantly topical, as it coats the lining of the intestines and stools without systemic absorption. The elimination of paraffinum is primarily through feces, as it is excreted unchanged.

Contra-indications

• Hypersensitivity to mineral oil
• Intestinal obstruction
• Severe abdominal pain of unknown origin

Adverse effects

• Abdominal cramps
• Diarrhea
• Nausea
• Vomiting
• Aspiration pneumonia
• Lipid pneumonia

Interactions

• May interfere with the absorption of fat-soluble vitamins (A, D, E, K)
• Caution with other laxatives

Precautions

• Use with caution in patients with renal impairment
• Avoid prolonged use
• Monitor for signs of aspiration

Pregnancy

Generally considered safe for use during pregnancy, but consult a healthcare provider.

Breast-feeding

Considered safe during breastfeeding, but consult a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Liquid paraffin
• Soft paraffin

Indications

• Personal fragrance enhancement
• Mood enhancement
• Social interaction
• Cosmetic use

Dosage

Children: Perfume is not typically recommended for use in children due to the potential for skin irritation and allergic reactions. Refer to guidelines for specific products.

Adults: Perfume is applied as desired, typically in small amounts to pulse points such as the wrists, neck, or behind the ears.

Mechanism of action

The mechanism of action of perfume involves the interaction of volatile aromatic compounds with olfactory receptors in the nasal cavity. These receptors send signals to the brain, which interprets the scent, triggering emotional and physiological responses. Perfumes can influence mood, evoke memories, and enhance social interactions by engaging the limbic system, which is involved in emotion and memory.

Pharmacodynamics

Perfume does not have pharmacodynamic effects in the traditional sense as medicinal drugs do. However, certain components may have mild effects on mood and emotional well-being by stimulating the olfactory system. Essential oils present in some perfumes may also have mild antidepressant or relaxing properties, although these effects are not clinically significant.

Pharmacokinetics

Perfume is primarily applied topically to the skin or clothing, where it evaporates and releases fragrance into the air. The compounds in perfume can be absorbed through the skin, but systemic absorption is generally low. The duration and intensity of fragrance depend on the volatility of the components used and their concentration. The scent usually lasts from a few hours to a day, depending on the formulation and individual skin chemistry.

Adverse effects

• Skin irritation
• Allergic reactions
• Headaches
• Respiratory issues
• Nausea

Precautions

• Use with caution in individuals with sensitive skin or allergies
• Avoid direct contact with eyes
• Use in well-ventilated areas to prevent respiratory irritation

Pregnancy

Generally regarded as safe in pregnancy, but some fragrances may cause allergic reactions or sensitivities.

Breast-feeding

Generally considered safe, but individual fragrances should be assessed for potential allergens.

Storage

Store in a cool, dry place away from direct sunlight and heat sources.

Formulations

• Eau de parfum
• Eau de toilette
• Cologne
• Perfume oil
• Body spray

Dosage

Children: There are no established therapeutic doses for toluene in pediatric populations due to its potential for abuse and toxicity. Exposure should be avoided.

Adults: There are no established therapeutic doses for toluene due to its potential for abuse and toxicity. Exposure should be minimized as per occupational safety guidelines.

Mechanism of action

Toluene primarily affects the dopaminergic mechanisms of the basal ganglia, leading to alterations in sensory-motor integration. At low concentrations, it reduces dopamine turnover in the anterior nucleus caudate, while at higher concentrations, it increases dopamine turnover in the cholecystokinin-dopamine terminals of the limbic system, contributing to its euphoric effects. Toluene also influences various neurotransmitter systems, including glutamate and GABA, and alters the activities of neurotransmitter synthesizing enzymes, which can indicate permanent loss of neuronal activity.

Pharmacodynamics

Toluene exhibits central nervous system depressant effects, which can lead to symptoms such as euphoria, dizziness, and cognitive impairment. Chronic exposure may result in neurotoxic effects, including potential damage to catecholaminergic neurons and changes in neurotransmitter levels. The drug's psychoactive effects are associated with its ability to modulate dopamine pathways, ultimately affecting mood, perception, and motor coordination.

Pharmacokinetics

Toluene is rapidly absorbed through inhalation and can distribute throughout the body, with a high affinity for fatty tissues. It undergoes metabolic degradation primarily in the liver, where it is converted into various metabolites. The elimination half-life of toluene varies depending on the route of exposure and the concentration, with significant excretion occurring through urine as metabolites, including hippuric acid.

Adverse effects

• CNS depression
• Dizziness
• Headaches
• Nausea
• Vomiting
• Respiratory irritation
• Cognitive impairment
• Potential for addiction and euphoric effects

Precautions

• Use with caution in individuals with pre-existing neurological disorders
• Avoid exposure in pregnant women due to potential risks to fetal development
• Monitor for signs of abuse in individuals with a history of substance misuse

Pregnancy

Toluene exposure during pregnancy may pose risks to fetal development, including potential teratogenic effects. Caution is advised.

Breast-feeding

Due to the potential for adverse effects, breastfeeding is not recommended during exposure to toluene.

Storage

Store in a cool, well-ventilated area away from sources of ignition. Keep container tightly closed.

Formulations

• Inhalation vapors
• Solvent formulations

Indications

• Musculoskeletal pain
• Arthritis
• Tendinitis
• Back pain
• Muscle strains and sprains

Dosage

Children: Refer to the BNF for Children for specific dosing guidelines.

Adults: Apply to the affected area, usually 3 to 4 times daily as needed, ensuring not to exceed the recommended amount.

Mechanism of action

Counter-irritation is thought to be effective at alleviating musculoskeletal pain as the irritation of the sensory nerve endings alters or offsets pain in the underlying muscle or joints served by the same nerves. When applied topically, methyl salicylate penetrates the skin and underlying tissues, where it reversibly inhibits cyclooxygenase enzyme and prevents the production of inflammatory mediators such as prostaglandin and thromboxane A2.

Pharmacodynamics

Methyl salicylate relieves musculoskeletal pain in muscles, joints, and tendons by causing irritation and reddening of the skin due to dilated capillaries and increased blood flow. It acts as a rubefacient and skin irritant, providing a soothing sensation of warmth. Its pharmacological profile is similar to that of aspirin and other NSAIDs.

Pharmacokinetics

Methyl salicylate is absorbed through the skin upon topical application, where it exerts its effects locally. It undergoes metabolism primarily in the liver, and its metabolites are excreted via urine. The onset of action is relatively rapid, given the local application.

Adverse effects

• Skin irritation
• Allergic reactions
• Burning sensation at the application site

Precautions

• Avoid contact with eyes and mucous membranes
• Do not apply to broken or irritated skin
• Use with caution in patients with sensitive skin or allergies

Pregnancy

Data on the safety of wintergreen during pregnancy is limited. Consult a healthcare professional before use.

Breast-feeding

Limited data available; consult a healthcare professional before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Topical ointment
• Topical gel
• Liniment

Mechanism of action

Capsaicin has been shown to reduce the amount of substance P associated with inflammation - however this is not believed to be its main mechanism in the relief of pain. Capsaicin's mechanism of action is attributed to "defunctionalization" of nociceptor fibers by inducing a topical hypersensitivity reaction on the skin. This alteration in pain mechanisms is due to many of the following: temporary loss of membrane potential, inability to transport neurotrophic factors leading to altered phenotype, and reversible retraction of epidermal and dermal nerve fiber terminals. Capsaicin, the pungent constituent of chili peppers, represents the paradigm for the capsaicinoids or vanilloids, a family of compounds shown to stimulate and then desensitize specific subpopulations of sensory receptors, including C-polymodal nociceptors, A-delta mechanoheat nociceptors and warm receptors of the skin, as well as enteroceptors of thin afferent fibers. ... ... In rats desensitized by intraperitoneal (ip) capsaicin (i.e., abdominal non-systemic desensitization), mainly the first but not the later fever phases were reduced. The postprandial hyperthermia to intragastric injection of BaSO4 suspension was attenuated by either ip or perineural capsaicin treatment. ... Heat and protons as well as capsaicin activate VR1 to induce the influx of cations, particularly Ca2+ and Na+ ions. Characteristic effects of capsaicin are the induction of a burning sensation after acute administration and the desensitization of sensory neurons after large doses and prolonged administration. ... Capsaicin alters several visceral functions. ... Capsaicin affects thermoregulation after intra-hypothalamic injection and releases glutamate from the hypothalamus and cerebral cortex slices, while VR1-like immunoreactivity is not apparent in these regions. ... 0.4 and 4 uM of capsaicin produced a significant tonic block on voltage-activated Na+ current (I(Na)) evoked by a depolarizing step to -40 mV from a holding potential of -100 mV (49 +/- 7% n=11, p<0.05 and 72 +/- 13% n=4, p<0.05 respectively). ... Capsaicin slowed the time decay of inactivation of I(Na), and increased the time constant of the recovery of inactivation. Capsaicin and tetrodotoxin (TTX) depressed contractility of isolated electrically driven left rat atria, being the depression of maximal velocity of force development (dF/dt(max)) with respect to control values of 19 +/- 3% at 1 uM of capsaicin and 22 +/- 2% at 1 uM of TTX. For more Mechanism of Action (Complete) data for CAPSAICIN (8 total), please visit the HSDB record page.

Pharmacodynamics

Capsaicin is a TRPV1 receptor agonist. TRPV1 is a trans-membrane receptor-ion channel complex activated by temperatures higher than 43 degrees Celsius, pH lower than 6, and endogenous lipids. When activated by a combination of these factors, the channel can transiently open and initiate depolarization due to the influx of calcium and sodium ions. Because TRPV1 is commonly expressed in A-delta and mostly C fibers, depolarization results in action potentials which send impulses to the brain and spinal cord. These impulses result in capsaicin effects of warming, tingling, itching, stinging, or burning. Capsaicin also causes more persistent activation of these receptors compared to the environmental agonists, resulting in a loss of response to many sensory stimuli, described as "defunctionalization". Capsaicin is associated with many enzymatic, cytoskeletal, and osmotic changes, as well as disruption of mitochondrial respiration, impairing nociceptor function for extended periods of time.

Mechanism of action

Camphor is a naturally occurring compound that is used as a major active ingredient of balms and liniments supplied as topical analgesics. ... Capsaicin and menthol, two other topically applied agents widely used for similar purposes, are known to excite and desensitize sensory nerves by acting on two members of transient receptor potential (TRP) channel superfamily: heat-sensitive TRP vanilloid subtype 1 (TRPV1) and cold-sensitive TRP channel M8, respectively. Camphor has recently been shown to activate TRPV3, and here /investigators/ show that camphor also activates heterologously expressed TRPV1, requiring higher concentrations than capsaicin. Activation was enhanced by phospholipase C-coupled receptor stimulation mimicking inflamed conditions. Similar camphor-activated TRPV1-like currents were observed in isolated rat DRG neurons and were strongly potentiated after activation of protein kinase C with phorbol-12-myristate-13-acetate. Camphor activation of rat TRPV1 was mediated by distinct channel regions from capsaicin, as indicated by camphor activation in the presence of the competitive inhibitor capsazepine and in a capsaicin-insensitive point mutant. Camphor did not activate the capsaicin-insensitive chicken TRPV1. TRPV1 desensitization is believed to contribute to the analgesic actions of capsaicin. /The authors/ found that, although camphor activates TRPV1 less effectively, camphor application desensitized TRPV1 more rapidly and completely than capsaicin. Conversely, TRPV3 current sensitized after repeated camphor applications, which is inconsistent with the analgesic role of camphor. /Investigators/ also found that camphor inhibited several other related TRP channels, including ankyrin-repeat TRP 1 (TRPA1). The camphor-induced desensitization of TRPV1 and block of TRPA1 may underlie the analgesic effects of camphor.

Mechanism of action

Exposure to low temperatures often causes allergic responses or urticaria. Similarly, menthol, a common food additive is also known to cause urticaria, asthma, and rhinitis. However, despite the obvious clinical implications, the molecular mechanisms responsible for inducing allergic responses to low temperatures and menthol have not been determined. Because a non-selective cation channel, transient receptor potential subtype M8 (TRPM8) is activated by cold and menthol, we hypothesized that this channel mediates cold- and menthol-induced histamine release in mast cells. Here, we report that TRPM8 is expressed in the basophilic leukemia mast cell line, RBL-2H3, and that exposure to menthol or low temperatures induced Ca(2+) influx in RBL-2H3 cells, which was reversed by a TRPM8 blocker. Furthermore, menthol, a TRPM8 agonist, induced the dose-dependent release of histamine from RBL-2H3 cells. When TRPM8 transcripts were reduced by siRNA (small interfering RNA), menthol- and cold-induced Ca(2+) influx and histamine release were significantly reduced. In addition, subcutaneous injection of menthol evoked scratching, a typical histamine-induced response which was reversed by a TRPM8 blocker. Thus, our findings indicate that TRPM8 mediates the menthol- and cold-induced allergic responses of mast cells, and suggest that TRPM8 antagonists be viewed as potential treatments for cold- and menthol-induced allergies. /DL-Menthol/ Menthol's characteristic cooling sensation is due, in part, to the activation of sensory neurons generally termed transient receptor potential (TRP) channels, in particular transient receptor potential melastatin family member 8 (TRPM8) and transient receptor potential subfamily A, member 1 (TRPA1). Menthol acts upon TRPM8 receptors by rapidly increasing intracellular calcium and mobilizing calcium flux through the channels to induce cold response signals at the application site. Aside from its cold-inducing sensation capabilities, menthol exhibits cytotoxic effects in cancer cells, induces reduction in malignant cell growth, and engages in synergistic excitation of GABA receptors and sodium ion channels resulting in analgesia. /DL-Menthol/ In recent years, the transient receptor potential melastatin member 8 (TRPM8) channel has emerged as a promising prognostic marker and putative therapeutic target in prostate cancer. We have found that forced overexpression of TRPM8 in PC-3 cells can inhibit the cell proliferation and motility probably through the TRPM8 activation. In this study, we aimed to investigate whether activating the TRPM8 channel by its selective agonist menthol can inhibit the proliferation and motility of androgen-independent prostate cancer (AIPC) with remarkable expression of TRPM8. Menthol is a naturally occurring compound, which has been widely used in cosmetics and pharmaceutical products, and also as flavoring in food. DU145 cells are androgen-independent but have a remarkable expression of TRPM8. The demonstration of the existence of TRPM8 and the absence of TRPA1 in DU145 cells provided the foundation for the following experiments, because both TRPM8 and TRPA1 are molecular targets of menthol. The outcome of MTT assay indicated that menthol inhibited the cell growth (p < 0.01). Cell cycle distribution and scratch assay analysis revealed that menthol induced cell cycle arrest at the G(0)/G(1) phase (p < 0.01). Furthermore, menthol inhibited the migration of DU145 cells by downregulating the focal-adhesion kinase. So it suggests that the activation of the existing TRPM8 channels may serve as a potential and pragmatic treatment for those AIPC with remarkable expression of TRPM8, and menthol is a useful compound for future development as an anticancer agent. /DL-Menthol/

Mechanism of action

The present study demonstrates reductions of dopamine (DA) turnover in various areas of the anterior nucleus caudate of rat by toluene at concentrations lower than the current OSHA threshold limit value (100 ppm). Thus, toluene at low concentrations may produce disturbances in dopaminergic mechanisms of the basal ganglia probably leading to functional changes in sensory-motor integration. The increases in DA turnover in the cholecystokinin (CCK)-DA terminals of the subcortical limbic system induced by high concentrations of toluene may be part of the neurochemical basis for its abuse as a euphoric agent in man. Exposure to toluene causes both reversible and irreversible changes in the central nervous system. The effects of toluene inhalation on some specific enzymes and glutamate and GABA receptor binding in defined parts of the rat brain were studied following several exposure schemes. The activities of the transmitter synthesizing enzymes glutamic acid decarboxylase (GAD), choline acetyltransferase (ChAT) and aromatic amino-acid decarboxylase (AAD) were used as markers for permanent loss of neuronal activity. Catecholaminergic neurons showed a 50% reduction in the brain stem after 4 weeks exposure to 250 and 1000 ppm toluene. Following 500 ppm of toluene, 16 hr/day for 3 months, a general increase in the activities was seen. This is most probably due to a reduction in total protein content, to which the activities were related. The neurotransmitters glutamate and GABA had their specific receptor binding increased in most of the brain areas studied, but decreased in some areas. The glial enzyme, glutamine synthetase, has its activity increased in the cerebellar hemisphere following 4 weeks exposure to 1000 ppm. This suggests that glial cells in the area may have proliferated, a frequent phenomenon following CNS damage. The effect on energetic metabolism of rat liver mitochondria (RLM) of styrene and other aliphatic benzene derivatives, i.e. toluene, ethylbenzene, alpha-methylstyrene and butylbenzene, is studied. It is shown that these compounds uncouple oxidative phosphorylation and this effect is connected with the stimulation of passive entry of protons into mitochondria. The relationship between hydrophobicity of these compounds and their biological activity and mechanism of uncoupling effect are discussed.

Mechanism of action

Counter-irritation is thought to be effective at alleviating musculoskeletal pain as the irritation of the sensory nerve endings is thought to alter or offset pain in the underlying muscle or joints that are served by the same nerves. This is thought to mask the underlying musculoskeletal pain and discomfort. When applied topically, methyl salicylate is thought to penetrate the skin and underlying tissues where it reversibly inhibits cyclooxygenase enzyme and locally and peripherally prevents the production of inflammatory mediators such as prostaglandin and thromboxane A2.

Pharmacodynamics

Methyl salicylate relieve musculoskeletal pain in the muscles, joints, and tendons by causing irritation and reddening of the skin due to dilated capillaries and increased blood flow. It is pharmacologically similar to aspirin and other NSAIDs but as a topical agent it primarily acts as a rubefacient and skin irritant. Counter-irritation is believed to cause a soothing sensation of warmth.